Company

OCULAR THERAPEUTIX, INC (OCUL)

Standardized SEC financial data for OCULAR THERAPEUTIX, INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001393434 · NASDAQ · Pharmaceutical Preparations.

Gross margin

87.3%

Operating margin

-519.8%

Net margin

-511.9%

Revenue growth (YoY)

-18.5%

Return on equity

-40.6%

Free cash flow

-$216.9M

Current ratio

15.39×

EPS (diluted)

$-1.42

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.4M	$43.5M	$51.5M	$58.4M	$63.7M	$52.0M
Cost of revenue	$2.1M	$4.4M	$4.5M	$5.3M	$5.6M	$6.6M
Gross profit	$15.3M	$39.1M	$47.0M	$53.2M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$229.8M	$165.9M	$104.1M	$197.6M	$393.7M	$738.7M
Inventory	$1.2M	$1.3M	$2.0M	$2.3M	$3.0M	$3.6M
Total current assets	$246.2M	$191.3M	$129.6M	$232.2M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$53.6M	-$65.5M	-$59.6M	-$70.2M	-$134.7M	-$204.9M
Capital expenditures	$841K	$1.2M	$3.7M	$6.1M	$1.3M	$12.0M
Free cash flow	-$54.4M	-$66.7M	-$63.3M	-$76.3M

Get OCUL data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/OCUL/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/OCUL/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View OCUL filings on SEC EDGAR →